Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
Vossler DG, Knake S, O'Brien TJ, Watanabe M, Brock M, Steiniger-Brach B, Williams P, Roebling R; SP0982 co-investigators. Vossler DG, et al. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1067-1075. doi: 10.1136/jnnp-2020-323524. Epub 2020 Aug 18. J Neurol Neurosurg Psychiatry. 2020. PMID: 32817358 Free PMC article. Clinical Trial.
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial.
Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC; HARMONY-CTP study group. Szakacs Z, et al. Among authors: poverennova i. Lancet Neurol. 2017 Mar;16(3):200-207. doi: 10.1016/S1474-4422(16)30333-7. Epub 2017 Jan 25. Lancet Neurol. 2017. PMID: 28129985 Clinical Trial.
[Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)].
Stakhovskaya LV, Shamalov NA, Khasanova DR, Melnikova EV, Agafiina AS, Golikov KV, Bogdanov EI, Yakupova AA, Roshkovskaya LV, Lukinykh LV, Lokshtanova TM, Poverennova IE, Shepankevich LA. Stakhovskaya LV, et al. Among authors: poverennova ie. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3. Vyp. 2):55-65. doi: 10.17116/jnevro20171173255-65. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28665371 Clinical Trial. Russian.
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
[Clinical results and prospects for the use of phenosanic acid in patients with focal epilepsy].
Burd SG, Lebedeva AV, Pantina NV, Rubleva YV, Pizova NV, Vasil'ev SV, Belova AN, Vorob'eva OV, Emel'yanova VV, Zhadnov VA, Ivanova NE, Kalinin VV, Kissin MY, Kotov SV, Maksimova NE, Mihajlov VA, Novikov AE, Poverennova IE, Yamin MA. Burd SG, et al. Among authors: poverennova ie. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(10):52-59. doi: 10.17116/jnevro202112110152. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 34874655 Clinical Trial. Russian.
[Diagnosis and treatment of cognitive impairment in patients with chronic cerebral ischemia: the results of observational Russian program DIAMANT].
Parfenov VA, Zhivolupov SA, Nikulina KV, Poverennova IE, Lapatuhin VG, Zhestikova MG, Zhukova NG, Glazunov AB. Parfenov VA, et al. Among authors: poverennova ie. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6):15-23. doi: 10.17116/jnevro20181186115. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30040796 Russian.
48 results